首页> 美国卫生研究院文献>The Journal of Experimental Medicine >A Soluble Form of B Cell Maturation Antigen a Receptor for the Tumor Necrosis Factor Family Member April Inhibits Tumor Cell Growth
【2h】

A Soluble Form of B Cell Maturation Antigen a Receptor for the Tumor Necrosis Factor Family Member April Inhibits Tumor Cell Growth

机译:B细胞成熟抗原的可溶性形式肿瘤坏死因子家族成员四月的受体抑制肿瘤细胞的生长

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A proliferation-inducing ligand (APRIL) is a ligand of the tumor necrosis factor (TNF) family that stimulates tumor cell growth in vitro and in vivo. Expression of APRIL is highly upregulated in many tumors including colon and prostate carcinomas. Here we identify B cell maturation antigen (BCMA) and transmembrane activator and calcium modulator and cyclophilin ligand (CAML) interactor (TACI), two predicted members of the TNF receptor family, as receptors for APRIL. APRIL binds BCMA with higher affinity than TACI. A soluble form of BCMA, which inhibits the proliferative activity of APRIL in vitro, decreases tumor cell proliferation in nude mice. Growth of HT29 colon carcinoma cells is blocked when mice are treated once per week with the soluble receptor. These results suggest an important role for APRIL in tumorigenesis and point towards a novel anticancer strategy.
机译:诱导增殖的配体(APRIL)是肿瘤坏死因子(TNF)家族的配体,可在体外和体内刺激肿瘤细胞的生长。 APRIL的表达在包括结肠癌和前列腺癌在内的许多肿瘤中高度上调。在这里我们确定B细胞成熟抗原(BCMA)和跨膜激活剂和钙调节剂和亲环蛋白配体(CAML)相互作用体(TACI),这是TNF受体家族的两个预测成员,是APRIL的受体。 APRIL以比TACI高的亲和力结合BCMA。 BCMA的可溶形式在体外抑制APRIL的增殖活性,可减少裸鼠中的肿瘤细胞增殖。当每周用可溶性受体处理小鼠一次时,HT29结肠癌细胞的生长被阻断。这些结果表明APRIL在肿瘤发生中的重要作用,并指向一种新的抗癌策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号